PAPER
Multicomponent Synthesis of b-Acetamido Carbonyl Compounds
805
ed to column chromatography (silica gel, hexane–EtOAc) to afford
the pure b-acetamido carbonyl compound.
N-[1-(2-Naphthyl)-3-oxo-3-phenylpropyl]acetamide (4k)
IR (KBr): 3274, 1681, 1640, 1548, 1373, 1299 cm–1.
1H NMR (200 MHz, CDCl3): d = 8.32 (1 H, br d, J = 8.0 Hz), 7.98–
7.35 (12 H, m), 5.60 (1 H, m), 3.66 (1 H, dd, J = 12.0, 4.0 Hz), 3.40
(1 H, dd, J = 12.0, 2.0 Hz), 1.86 (3 H, s).
13C NMR (50 MHz, CDCl3): d = 198.6, 169.8, 139.2, 137.0, 133.6,
133.1, 132.5, 128.6, 128.4, 128.0, 127.8, 127.5, 126.1, 125.6, 125.3,
124.9, 50.0, 43.3, 23.4.
N-[3-Oxo-3-phenyl-1-(3,4,5-trimethoxyphenyl)propyl]acet-
amide (4e)
IR (KBr): 3277, 1687, 1646, 1558, 1246 cm–1.
1H NMR (200 MHz, CDCl3): d = 7.89 (2 H, d, J = 8.0 Hz), 7.53 (1
H, t, J = 8.0 Hz), 7.41 (2 H, t, J = 8.0 Hz), 6.70 (1 H, d, J = 8.0 Hz),
6.50 (2 H, s), 5.39 (1 H, m), 3.80 (6 H, s), 3.75 (3 H, s), 3.69 (1 H,
dd, J = 12.0, 2.0 Hz), 3.31 (1 H, dd, J = 12.0, 4.0 Hz), 2.01 (3 H, s).
ESI-MS: m/z = 318 [M + H]+.
13C NMR (50 MHz, CDCl3): d = 197.2, 169.0, 153.2, 150.0, 138.5,
137.2, 136.8, 134.6, 128.1, 127.8, 103.8, 60.0, 55.3, 49.5, 44.9,
22.6.
Anal. Calcd for C21H19NO2: C, 79.50; H, 5.99; N, 4.42. Found: C,
79.41; H, 5.96; N, 4.36.
N-[2-Methyl-1-(2-naphthyl)-3-oxo-3-phenylpropyl]acetamide
(anti-4n)
ESI-MS: m/z = 358 [M + H]+.
Anal. Calcd for C20H23NO5: C, 67.23; H, 6.44; N, 3.92. Found: C,
67.12; H, 6.41; N, 3.84.
IR (KBr): 3418, 1651, 1025 cm–1.
1H NMR (200 MHz, CDCl3): d = 8.24 (1 H, d, J = 8.0 Hz), 8.01 (2
H, d, J = 8.0 Hz), 7.80–7.74 (5 H, br s), 7.60–7.39 (5 H, m), 5.81 (1
H, t, J = 8.0 Hz), 4.06 (1 H, m), 1.66 (3 H, s), 0.88 (3 H, d, J = 7.0
Hz).
13C NMR (50 MHz, CDCl3): d = 202.2, 168.1, 138.6, 135.4, 131.5,
131.0, 128.2, 127.5, 127.2, 125.8, 125.4, 125.1, 54.9, 44.8, 21.4,
15.1.
N-[1-(3-Chloro-4-fluorophenyl)-3-oxo-3-phenylpropyl]acet-
amide (4g)
IR (KBr): 3285, 1688, 1648, 1548, 1499, 1253 cm–1.
1H NMR (200 MHz, CDCl3): d = 7.88 (2 H, d, J = 8.0 Hz), 7.57 (1
H, t, J = 8.0 Hz), 7.42 (2 H, t, J = 8.0 Hz), 7.34 (1 H, br d, J = 8.0
Hz), 7.19 (1 H, m), 7.02 (1 H, t, J = 8.0 Hz), 6.82 (1 H, d, J = 8.0
Hz), 5.45 (1 H, m), 3.80 (1 H, dd, J = 12.0, 2.0 Hz), 3.38 (1 H, dd,
J = 12.0, 4.0 Hz), 2.02 (3 H, s).
13C NMR (50 MHz, CDCl3): d = 199.1, 169.9, 159.5, 155.1, 139.6,
136.2, 134.8, 129.8, 129.0, 126.2, 117.1 (d, J = 10.0 Hz), 49.6,
44.3, 24.0.
ESI-MS: m/z = 332 [M + H]+.
Anal. Calcd for C22H21NO2: C, 79.76; H, 6.34; N, 4.23. Found: C,
79.82; H, 6.30; N, 4.17.
N-[2-Methyl-1-(2-naphthyl)-3-oxo-3-phenylpropyl]acetamide
(syn-4n)
ESI-MS: m/z = 320 [M + H]+.
IR (KBr): 3418, 1650, 1025 cm–1.
Anal. Calcd for C17H15ClFNO2: C, 63.85; H, 4.70; N, 4.38. Found:
C, 63.77; H, 4.67; N, 4.35.
1H NMR (200 MHz, CDCl3): d = 7.91 (2 H, d, J = 8.0 Hz), 7.75–
7.70 (4 H, m), 7.51 (1 H, t, J = 8.0 Hz), 7.46–7.38 (5 H, m), 6.19 (1
H, d, J = 6.0 Hz), 5.53 (1 H, dd, J = 6.0, 4.0 Hz), 4.12 (1 H, m), 1.95
(3 H, s), 1.19 (3 H, d, J = 7.0 Hz).
13C NMR (50 MHz, CDCl3): d = 201.8, 168.7, 149.9, 139.3, 133.2,
132.5, 128.8, 127.8, 127.6, 127.4, 126.1, 125.7, 125.4, 54.3, 45.0,
22.5, 14.5.
N-[1-(3-Chloro-4-fluorophenyl)-3-(4-chlorophenyl)-3-oxopro-
pyl]acetamide (4h)
IR (KBr): 3278, 1688, 1647, 1550, 1498, 1237 cm–1.
1H NMR (200 MHz, CDCl3): d = 8.20 (1 H, m), 7.93 (2 H, d, J = 8.0
Hz), 7.50–7.41 (3 H, m), 7.30 (1 H, m), 7.11 (1 H, m), 5.39 (1 H,
m), 3.56 (1 H, dd, J = 12.0, 4.0 Hz), 3.29 (1 H, dd, J = 12.0, 2.0
Hz), 1.85 (3 H, s).
13C NMR (50 MHz, CDCl3): d = 196.2, 168.8, 158.3, 154.9, 140.2,
138.6, 135.0, 130.0, 128.7, 127.5, 119.1 (d, J = 10.0 Hz), 117.4 (d,
J = 10.0 Hz), 48.0, 44.8, 22.6.
ESI-MS: m/z = 332 [M + H]+.
Anal. Calcd for C22H21NO2: C, 79.76; H, 6.34; N, 4.23. Found: C,
79.65; H, 6.28; N, 4.16.
N-[2-Acetyl-1-(2-naphthyl)-3-oxobutyl]acetamide (4q)
IR (KBr): 3286, 1722, 1646, 1544, 1366 cm–1.
ESI-MS: m/z = 354 (35Cl/35Cl [M + H]+), 356 (35Cl/37Cl [M + H]+),
1H NMR (200 MHz, CDCl3): d = 8.17 (1 H, d, J = 8.0 Hz), 7.86–
7.64 (4 H, m), 7.58 (1 H, d, J = 8.0 Hz), 7.48–7.41 (2 H, m), 5.82 (1
H, t, J = 8.0 Hz), 4.48 (1 H, d, J = 8.0 Hz), 2.22 (3 H, s), 1.98 (3 H,
s), 1.86 (3 H, s).
358 (37Cl/37Cl [M + H]+).
Anal. Calcd for C17H14Cl2FNO2: C, 57.63; H, 3.96; N, 3.96. Found:
C, 57.55; H, 3.94; N, 3.92.
13C NMR (50 MHz, CDCl3): d = 201.3, 200.9, 169.0, 137.4, 133.4,
132.8, 129.2, 129.0, 127.9, 126.0, 125.4, 125.2, 125.0, 72.1, 51.5,
30.2, 29.5, 22.0.
N-{(2E)-1-[2-(4-Chlorophenyl)-2-oxoethyl]-3-phenylprop-2-en-
1-yl}acetamide (4j)
IR (KBr): 3284, 1684, 1643, 1367, 1295 cm–1.
ESI-MS: m/z = 298 [M + H]+.
1H NMR (200 MHz, CDCl3): d = 7.91 (2 H, d, J = 8.0 Hz), 7.45 (2
H, d, J = 8.0 Hz), 7.32–7.12 (5 H, m), 6.55 (1 H, d, J = 14.0 Hz),
6.48 (1 H, d, J = 8.0 Hz), 6.31 (1 H, dd, J = 12.0, 7.0 Hz), 5.02 (1
H, m), 3.51 (1 H, dd, J = 12.0, 2.0 Hz), 3.29 (1 H, dd, J = 12.0, 4.0
Hz), 2.03 (3 H, s).
13C NMR (50 MHz, CDCl3): d = 198.2, 169.8, 140.1, 137.4, 135.5,
132.4, 129.9, 129.5, 129.2, 129.0, 128.6, 128.1, 127.3, 48.0, 42.5,
22.8.
Anal. Calcd for C18H19NO3: C, 72.73; H, 6.40; N, 4.71. Found: C,
72.58; H, 6.38; N, 4.66.
Ethyl 2-[(Acetylamino)(3,4,5-trimethoxyphenyl)methyl]-
3-oxobutanoate (anti-4r)
IR (KBr): 3296, 1719, 1651, 1593, 1463 cm–1.
1H NMR (200 MHz, CDCl3): d = 8.20 (1 H, d, J = 8.0 Hz), 6.62 (2
H, s), 5.57 (1 H, t, J = 8.0 Hz), 4.00 (2 H, q, J = 7.0 Hz), 3.95 (1 H,
d, J = 8.0 Hz), 3.84 (6 H, s), 3.70 (3 H, s), 2.26 (3 H, s), 1.82 (3 H,
s), 1.20 (3 H, t, J = 7.0 Hz).
ESI-MS: m/z = 328 (35Cl [M + H]+), 330 (37Cl [M + H]+).
Anal. Calcd for C19H18ClNO2: C, 69.62; H, 5.50; N, 4.28. Found: C,
69.55; H, 5.48; N, 4.26.
Synthesis 2010, No. 5, 803–806 © Thieme Stuttgart · New York